D. Bumbacea (Bucuresti, Romania), R. Lee (Beaconsfield, Buckinghamshire, United Kingdom)
Detection of micrometastases in mediastinal lymph nodes by haematological analyser and flow cytometry-pilot study.
I. Kwiecien (Warszawa, Poland), E. Rutkowska (Warszawa, Poland), J. Bednarek (Warszawa, Poland), R. Sokolowski (Warszawa, Poland), A. Raniszewska (Warszawa, Poland), K. Jahnz- Rózyk (Warszawa, Poland), P. Rzepecki (Warszawa, Poland), J. Domagala-Kulawik (Warszawa, Poland)
|   |
Computed tomography derived body composition analysis predicts cachexia and survival in patients with lung cancer
T. Kerkhoff (Leipzig, Germany), J. Pappisch (Leipzig, Germany), N. Linder (Leipzig, Germany), H. Busse (Leipzig, Germany), A. Gläser (Leipzig, Germany), S. Taubenheim (Leipzig, Germany), H. Kuhn (Leipzig, Germany), H. Wirtz (Leipzig, Germany), A. Frille (Leipzig, Germany)
| |
Volatile biopsies in personalized molecular diagnosis and follow-up of lung adenocarcinoma
A. Tetik Vardarli (Izmir, Turkey), L. Pelit (Izmir, Turkey), T. Dizdas (Izmir, Turkey), S. Ozgur (Izmir, Turkey), C. Aldag (Izmir, Turkey), K. Korba (Izmir, Turkey), C. Celebi (Izmir, Turkey), E. Baysal (Izmir, Turkey), F. Pelit (Izmir, Turkey), O. Goksel (Izmir, Turkey), A. Veral (Izmir, Turkey), Y. Basbinar (Izmir, Turkey), C. Gunduz (Izmir, Turkey), T. Goksel (Izmir, Turkey)
| |
Proportion of mediastinal lymph nodes that cross predefined borders on the IASLC map.
Ø. Yksnøy (Ålesund, Norway), D. Arne Liaug Hoff (Ålesund, Norway), B. Henning Grønbereg (Trondheim, Norway), K. Roth (Aalesund, Norway)
| |
Mediastinal "deep freeze" - transcarinal lymph node cryobiopsy
E. Gershman (Tel Aviv, Israel), A. Ikan (Tel Aviv, Israel), B. Pertzov (Tel Aviv, Israel), D. Rosengarten (Tel Aviv, Israel), M. Kramer (Tel Aviv, Israel)
| |
Malignant pleural effusion (MPE) diagnosis with medical thoracoscopy (MT) compared with conventional approaches
G. Hardavella (Athens, Greece), I. Karampinis (Athens, Greece), A. Katsipoulakis (Athens, Greece), N. Anastasiou (Athens, Greece)
| |
Correlation of PD-L1 expression on tumour cells between diagnostic biopsies and surgical specimens of lung cancer in real life with respect to biopsy techniques and neoadjuvant treatment
D. Gompelmann (Vienna, Austria), K. Sinn (Vienna, Austria), J. Brugger (Vienna, Austria), D. Bernitzky (Vienna, Austria), B. Mosleh (Vienna, Austria), H. Prosch (Vienna, Austria), S. Geleff (Vienna, Austria), A. Blessing (Vienna, Austria), A. Tiefenbacher (Vienna, Austria), K. Hoetzenecker (Vienna, Austria), M. Idzko (Vienna, Austria), M. Hoda (Vienna, Austria)
| |
A comparison of the biopsy techniques for tissue subtyping and molecular profiling in non-small -call lung cancer: is tissue an issue?
P. Arooj (Plymouth, United Kingdom), I. Zaki (Plymouth, United Kingdom), M. Fayed (Plymouth, United Kingdom), H. Rai (Plymouth, United Kingdom), K. Syred (Plymouth, United Kingdom), R. Hadden (Plymouth, United Kingdom), L. Taylor (Plymouth, United Kingdom), T. Howell (Plymouth, United Kingdom), T. Nichsolson (Plymouth, United Kingdom), J. Corcoran (Plymouth, United Kingdom), C. Daneshvar (Plymouth, United Kingdom), M. Hassan (Alexandria, Egypt)
| |
Clarifying oligometastatic non-small cell lung cancer in patients with local ablative therapies for oligoprogression after tyrosine kinase inhibitors
D. Hyun (Seoul, Republic of Korea), Y. Jang (Seoul, Republic of Korea), W. Ji (Seoul, Republic of Korea), C. Choi (Seoul, Republic of Korea), D. Lee (Seoul, Republic of Korea), S. Kim (Seoul, Republic of Korea), S. Yoon (Seoul, Republic of Korea), W. Kim (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea)
| |
N2 institutional consensus on Non-Small Cell Lung Cancer (NSCLC)
H. Eid (Beirut, Lebanon), A. El Kik (Beirut, Lebanon), E. Karam (Beirut, Lebanon), A. Chamaa (Beirut, Lebanon), B. Habr (Beirut, Lebanon), F. El Karak (Beirut, Lebanon), H. Kourie (Beirut, Lebanon), F. Azouri (Beirut, Lebanon), V. Smayra (Beirut, Lebanon), N. Aoun (Beirut, Lebanon), J. Kattan (Beirut, Lebanon), G. Chahine (Beirut, Lebanon), M. Ghosn (Beirut, Lebanon), J. Wakim (Beirut, Lebanon), H. Nasserddine (Beirut, Lebanon), F. Nasr (Beirut, Lebanon), G. Khayat (Beirut, Lebanon), J. Nakad (Beirut, Lebanon), C. Harmouche (Beirut, Lebanon), G. Dabar (Beirut, Lebanon), G. Tabet (Beirut, Lebanon), Z. Aoun (Beirut, Lebanon), M. Riachy (Beirut, Lebanon)
| |
Detection of EGFR mutation status on pleural fluid samples in patient with lung adenocarcinoma
A. Navarra (Watford, United Kingdom), A. Maddox (Watford, United Kingdom), A. Barlow (Watford, United Kingdom), R. Mogal (Watford, United Kingdom)
| |
Impact of COVID-19 (C19) on EBUS-TBNA
M. Niazi (Redditch, United Kingdom), S. Tan (Redditch, United Kingdom), A. Lal (Redditch, United Kingdom)
| |
Trans thoracic CT-guided fine-needle biopsy of pulmonary lesions, predictive factors for complications and accuracy of diagnosis
K. Piotkovskaya (Stockholm, Sweden), E. Radeka (Stockholm, Sweden), S. Nyrén (Stockholm, Sweden), R. Karimi (Uppsala, Sweden)
| |